These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 28373723)

  • 1. Biosafety Level 3 setup for multiphoton microscopy in vivo.
    Barlerin D; Bessière G; Domingues J; Schuette M; Feuillet C; Peixoto A
    Sci Rep; 2017 Apr; 7(1):571. PubMed ID: 28373723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biosafety Oversight and Compliance: What do you Mean, I have to Fill Out Another Form?!
    Petrella BL
    Curr Protoc Microbiol; 2015 Nov; 39():1A.5.1-1A.5.16. PubMed ID: 26528783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biosafety and biosecurity measures: management of biosafety level 3 facilities.
    Zaki AN
    Int J Antimicrob Agents; 2010 Nov; 36 Suppl 1():S70-4. PubMed ID: 20801002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biocontainment design considerations for biopharmaceutical facilities.
    Miller SR; Bergmann D
    J Ind Microbiol; 1993 Jul; 11(4):223-34. PubMed ID: 7763894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Main Biological Hazards in Animal Biosafety Level 2 Facilities and Strategies for Control.
    Li XY; Xue KN; Jiang JS; Lu XC
    Biomed Environ Sci; 2016 Apr; 29(4):300-4. PubMed ID: 27241742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence-based biosafety: a review of the principles and effectiveness of microbiological containment measures.
    Kimman TG; Smit E; Klein MR
    Clin Microbiol Rev; 2008 Jul; 21(3):403-25. PubMed ID: 18625678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of regulations, safety considerations and physical limitations on research progress at maximum biocontainment.
    Shurtleff AC; Garza N; Lackemeyer M; Carrion R; Griffiths A; Patterson J; Edwin SS; Bavari S
    Viruses; 2012 Dec; 4(12):3932-51. PubMed ID: 23342380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biohazard sorting.
    Schmid I; Roederer M; Koup RA; Ambrozak D; Perfetto SP
    Methods Cell Biol; 2004; 75():221-40. PubMed ID: 15603428
    [No Abstract]   [Full Text] [Related]  

  • 9. Negative impact of laws regarding biosecurity and bioterrorism on real diseases.
    Wurtz N; Grobusch MP; Raoult D
    Clin Microbiol Infect; 2014 Jun; 20(6):507-15. PubMed ID: 24909400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. European perspective of 2-person rule for biosafety level 4 laboratories.
    Ippolito G; Nisii C; Di Caro A; Brown D; Gopal R; Hewson R; Lloyd G; Gunther S; Eickmann M; Mirazimi A; Koivula T; Georges Courbot MC; Raoul H; Capobianchi MR
    Emerg Infect Dis; 2009 Nov; 15(11):1858. PubMed ID: 19891889
    [No Abstract]   [Full Text] [Related]  

  • 11. International Society for Analytical Cytology biosafety standard for sorting of unfixed cells.
    Schmid I; Lambert C; Ambrozak D; Marti GE; Moss DM; Perfetto SP;
    Cytometry A; 2007 Jun; 71(6):414-37. PubMed ID: 17385740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biodefence lab criticized.
    Dolgin E
    Nature; 2009 Jul; 460(7255):556-7. PubMed ID: 19641559
    [No Abstract]   [Full Text] [Related]  

  • 13. [Biosafety manual concerning tests on tuberculosis bacilli, the first edition, 2005: compiled by Committee for Testing Acid-Fast Bacilli, the Japanese Society for Tuberculosis, the Japanese Society of Clinical Microbiology, and the Japanese Society of Clinical Technologists].
    Japanese Society for Tuberculosis, the Japanese Society of Clinical Microbiology, and the Japanese Society of Clinical Technologists
    Kekkaku; 2005 Jun; 80(6 Suppl):499-520. PubMed ID: 16128536
    [No Abstract]   [Full Text] [Related]  

  • 14. Certification & validation of biosafety level-2 & biosafety level-3 laboratories in Indian settings & common issues.
    Mourya DT; Yadav PD; Khare A; Khan AH
    Indian J Med Res; 2017 Oct; 146(4):459-467. PubMed ID: 29434059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resources for international biosafety guidelines and regulations.
    Curr Protoc Microbiol; 2005 Jul; Appendix 1():Appendix 1B. PubMed ID: 18770541
    [No Abstract]   [Full Text] [Related]  

  • 16. [Biosafety and biosecurity in the medical laboratory. Update and trends].
    Ionescu G; Neguţ M; Combiescu AA
    Bacteriol Virusol Parazitol Epidemiol; 2007; 52(3-4):91-9. PubMed ID: 19326721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The basics of animal biosafety and biocontainment training.
    Pritt S; Hankenson FC; Wagner T; Tate M
    Lab Anim (NY); 2007 Jun; 36(6):31-8. PubMed ID: 17519943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recommendations for working with pathogenic bacteria. HHS, NIH, CDC.
    Morse SA; McDade JE
    Methods Enzymol; 1994; 235():1-26. PubMed ID: 8057889
    [No Abstract]   [Full Text] [Related]  

  • 19. Laboratory-associated infections and biosafety.
    Sewell DL
    Clin Microbiol Rev; 1995 Jul; 8(3):389-405. PubMed ID: 7553572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges in Implementing a Biorisk Management Program at Universitas Indonesia: A Checklist Tool for Biorisk Management.
    Naroeni A; Bachtiar EW; Ibrahim F; Bela B; Kusminanti Y; Pujiriani I; Lestari F
    Health Secur; 2016; 14(6):375-381. PubMed ID: 27830940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.